Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Neon Bloom: Invitation to Investor Summit Group's Q2 In-Person Conference

NBCO

Columbia, Maryland--(Newsfile Corp. - April 29, 2022) - Neon Bloom (OTC Pink: NBCO) today announced that Walter Tabaschek, COO/CFO will be attending The Q2 Investor Summit Group - In-Person. This presentation is about a genetic operating platform called Cannabis Zero™, that introduces patented 0% THC cannabis plants and a patented 0% THC food ingredient called PECSA™.

Event: The Q2 Investor Summit Group
Date: May 3-4, 2022
Location: The Westin New York Grand Central
212 E 42nd St, New York, NY 10017
Presentation: May 3rd at 12:30PM ET
View webcast presentation: https://us06web.zoom.us/webinar/register/WN_l4ykglI9SvusYMm29sTuxg

About Neon Bloom

Bloom: Neon Bloom, Inc. (OTC Pink: NBCO), doing business as Bazelet Health Systems, Inc. ("Bazelet"), holds the exclusive license to grow in the United States a patented zero-THC, high CBG Cannabis sativa L plant which received United States Patent No. PP32,725 on January 5, 2021. The patented plant, which was named PAN2020, is remarkably high in Cannabigerol (CBG) with undetectable levels (zero percent) of both Cannabidiol (CBD) and Tetrahydrocannabinol (THC).Consistent with the company's mantra to create zero-THC products (the company's Cannabis-ZERO platform), the company is actively developing non-GMO cannabis Sativa plants that produce zero-THC while being rich in CBG and other valuable cannabinoids. Bazelet is a wholly-owned subsidiary of the public company that manufactures and markets PECSA, a patent-pending, proprietary full extract of the PAN2020 plant with other added proprietary ingredients. PECSA stands for Plant-based EndoCannabinoid System Activator. The EndoCannabinoid System is the premier regulatory center of the body affecting mental abilities, emotions, pain, inflammation, immune and metabolic functions with receptors found primarily in the brain and immune cells. The company's primary focus is to sell and market PECSA as a non-GMO, plant-based ingredient for the global food, drug, cosmetic, and tobacco industries. To meet the anticipated worldwide demand for PECSA, Bazelet has established a vertically integrated supply chain providing operational control from patented cannabis plants to proprietary patented plant processing to GMP-produced finishedproducts, all with traceability from seed to sale. Bazelet grows the patented plant in North America, Europe, South America, and the Middle East coming online in 2023. Processing and distribution facilities are located in the U.S. and Europe.

For further information:

Neon Bloom
Walter Tabaschek
(321) 558-2170
wtabaschek@bazelethealth.com

About the Investor Summit Group

The Investor Summit Group (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. The Q2 Investor Summit Group will take place in-person, featuring 65+ companies and over 300 investors comprising institutional investors, family offices, and high net worth investors. Sectors Participating: Biotech, Communication Services, Consumer, Energy, Energy/Tech, Financial, Healthcare, Industrials, Materials, Real Estate, Technology, and Tech/Crypt. info@investorsummitgroup.com.